Chee Conley - Insider Non-Derivative Transactions at Syros Pharmaceuticals, Inc. (SYRS) - (SEC)

Updated on January 3, 2026.

According to recent SEC insider information filed on Nov 18, 2024, Chee Conley's relationship to Syros Pharmaceuticals, Inc. (SYRS) is Director,Officer (President & CEO), and currently has 0 shares of Common Stock.

The chart below shows the number of shares owned, and the table shows the recent insider transactions.

You can see similar information for other SYRS insiders.

Related Topics: SEC Topic List.

Data Source: SEC.

Chee Conley - Insider Non-Derivative Transactions of SYRS Common Stock

Chee Conley - Insider Non-Derivative Transactions at SYRS

Items per page:

0 of 0

Date	Transaction	No. of Shares	Price Per Share	Shares Owned After Transactions
Nov 19, 2024	Sell -- (Common Stock)	134797	0.2	0
Nov 1, 2024	F -- (Common Stock)	8707	2.09	130797
Nov 1, 2024	M -- (Common Stock)	17000	0	139504
Sep 12, 2024	P -- (Common Stock)	50000	1.71	122504
Sep 11, 2024	P -- (Common Stock)	50000	1.51	72504
Apr 2, 2024	F -- (Common Stock)	3500	5.12	22504
Apr 1, 2024	M -- (Common Stock)	2000	0	14338
Apr 1, 2024	M -- (Common Stock)	11666	0	26004
Nov 2, 2023	F -- (Common Stock)	6004	2.22	12338
Nov 1, 2023	M -- (Common Stock)	17000	0	18342
Apr 4, 2023	F -- (Common Stock)	658	2.58	1342
Apr 1, 2023	M -- (Common Stock)	2000	0	2000